USP3 plays a critical role in the induction of innate immune tolerance

EMBO Rep. 2023 Dec 6;24(12):e57828. doi: 10.15252/embr.202357828. Epub 2023 Nov 16.

Abstract

Microbial products, such as lipopolysaccharide (LPS), can elicit efficient innate immune responses against invading pathogens. However, priming with LPS can induce a form of innate immune memory, termed innate immune "tolerance", which blunts subsequent NF-κB signaling. Although epigenetic and transcriptional reprogramming has been shown to play a role in innate immune memory, the involvement of post-translational regulation remains unclear. Here, we report that ubiquitin-specific protease 3 (USP3) participates in establishing "tolerance" innate immune memory through non-transcriptional feedback. Upon NF-κB signaling activation, USP3 is stabilized and exits the nucleus. The cytoplasmic USP3 specifically removes the K63-linked polyubiquitin chains on MyD88, thus negatively regulating TLR/IL1β-induced inflammatory signaling activation. Importantly, cytoplasmic translocation is a prerequisite step for USP3 to deubiquitinate MyD88. Additionally, LPS priming could induce cytoplasmic retention and faster and stronger cytoplasmic translocation of USP3, enabling it to quickly shut down NF-κB signaling upon the second LPS challenge. This work identifies a previously unrecognized post-translational feedback loop in the MyD88-USP3 axis, which is critical for inducing normal "tolerance" innate immune memory.

Keywords: NF-κB signaling; inflammatory response; innate immune memory; toll-like receptors; ubiquitination.

MeSH terms

  • Immune Tolerance
  • Immunity, Innate
  • Lipopolysaccharides / pharmacology
  • Myeloid Differentiation Factor 88* / genetics
  • NF-kappa B* / metabolism
  • Signal Transduction

Substances

  • NF-kappa B
  • Myeloid Differentiation Factor 88
  • Lipopolysaccharides